$4.86
3.62% yesterday
NYSE, Nov 14, 10:09 pm CET
ISIN
US67080N1019
Symbol
NUVB

Nuvation Bio Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation

Nuvation Bio Inc - Ordinary Shares - Class A Classifications & Recommendation:

Buy
93%
Hold
7%

Nuvation Bio Inc - Ordinary Shares - Class A Price Target

Target Price $10.20
Price $4.86
Potential
Number of Estimates 9
9 Analysts have issued a price target Nuvation Bio Inc - Ordinary Shares - Class A 2026 . The average Nuvation Bio Inc - Ordinary Shares - Class A target price is $10.20. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 13 Analysts recommend Nuvation Bio Inc - Ordinary Shares - Class A to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Nuvation Bio Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of . Most analysts recommend the Nuvation Bio Inc - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 7.87 30.17
283.32%
Net Margin -7,216.52% -757.22%
89.51%

10 Analysts have issued a sales forecast Nuvation Bio Inc - Ordinary Shares - Class A 2025 . The average Nuvation Bio Inc - Ordinary Shares - Class A sales estimate is

$30.2m
Unlock
. This is
12.77% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$48.1m 79.78%
Unlock
, the lowest is
$17.6m 34.06%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $7.9m
2025
$30.2m 283.32%
Unlock
2026
$133m 340.98%
Unlock
2027
$249m 87.00%
Unlock
2028
$383m 54.12%
Unlock
2029
$613m 59.78%
Unlock
2030
$829m 35.31%
Unlock
2031
$1.0b 24.38%
Unlock
2032
$1.2b 20.08%
Unlock

10 Nuvation Bio Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Nuvation Bio Inc - Ordinary Shares - Class A net profit estimate is

$-228m
Unlock
. This is
5.03% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-216m 0.71%
Unlock
, the lowest is
$-235m 8.12%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-568m 649.26%
2025
$-228m 59.78%
Unlock
2026
$-196m 14.23%
Unlock
2027
$-157m 19.70%
Unlock
2028
$21.0m 113.34%
Unlock

Net Margin

2024 -7,216.52%
2025
-757.22% 89.51%
Unlock
2026
-147.27% 80.55%
Unlock
2027
-63.24% 57.06%
Unlock
2028
5.47% 108.65%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -2.11 -0.67
502.86% 68.25%
P/E negative
EV/Sales 41.99

10 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast for earnings per share. The average Nuvation Bio Inc - Ordinary Shares - Class A EPS is

$-0.67
Unlock
. This is
4.69% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.63 1.56%
Unlock
, the lowest is
$-0.69 7.81%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.11 502.86%
2025
$-0.67 68.25%
Unlock
2026
$-0.57 14.93%
Unlock
2027
$-0.46 19.30%
Unlock
2028
$0.06 113.04%
Unlock
2029
$3.43 5,616.67%
Unlock

P/E ratio

Current -7.33 393.64%
2025
-7.04 3.93%
Unlock
2026
-8.21 16.62%
Unlock
2027
-10.22 24.48%
Unlock
2028
76.63 849.80%
Unlock

Based on analysts' sales estimates for 2025, the Nuvation Bio Inc - Ordinary Shares - Class A stock is valued at an EV/Sales of

41.99
Unlock
and an P/S ratio of
53.46
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 47.36 76.13%
2025
41.99 11.33%
Unlock
2026
9.52 77.32%
Unlock
2027
5.09 46.53%
Unlock
2028
3.30 35.12%
Unlock
2029
2.07 37.41%
Unlock
2030
1.53 26.09%
Unlock
2031
1.23 19.61%
Unlock
2032
1.02 16.72%
Unlock

P/S ratio

Current 60.28 86.57%
2025
53.46 11.33%
Unlock
2026
12.12 77.32%
Unlock
2027
6.48 46.52%
Unlock
2028
4.21 35.11%
Unlock
2029
2.63 37.41%
Unlock
2030
1.95 26.09%
Unlock
2031
1.56 19.60%
Unlock
2032
1.30 16.72%
Unlock

Current Nuvation Bio Inc - Ordinary Shares - Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citizens
Locked
Locked
Locked Nov 04 2025
RBC Capital
Locked
Locked
Locked Nov 04 2025
Wedbush
Locked
Locked
Locked Oct 13 2025
Jefferies
Locked
Locked
Locked Sep 30 2025
HC Wainwright & Co.
Locked
Locked
Locked Sep 19 2025
Wedbush
Locked
Locked
Locked Sep 08 2025
RBC Capital
Locked
Locked
Locked Aug 08 2025
Analyst Rating Date
Locked
Citizens:
Locked
Locked
Nov 04 2025
Locked
RBC Capital:
Locked
Locked
Nov 04 2025
Locked
Wedbush:
Locked
Locked
Oct 13 2025
Locked
Jefferies:
Locked
Locked
Sep 30 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Sep 19 2025
Locked
Wedbush:
Locked
Locked
Sep 08 2025
Locked
RBC Capital:
Locked
Locked
Aug 08 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today